Literature DB >> 20510263

Advances in the understanding of the pathogenesis and epidemiology of herpes zoster.

Anne A Gershon1, Michael D Gershon, Judith Breuer, Myron J Levin, Anne Louise Oaklander, Paul D Griffiths.   

Abstract

The primary varicella zoster virus (VZV) infection results in chickenpox (varicella), which is transmitted via the airborne route. VZV is highly infectious, but in the USA the incidence of varicella has been reduced by 76-87% as a result of the varicella vaccine. The virus establishes latency in the dorsal root ganglia during varicella and, when reactivated, travels along the sensory nerve axons to cause shingles (herpes zoster [HZ]). There are over 1 million cases of HZ in the USA each year, with an estimated lifetime attack rate of 30%. The incidence of HZ, which causes significant morbidity, increases with age and reaches approximately 10 cases per 1,000 patient-years by age 80. Cell-mediated immunity (CMI) is known to decline with age as part of immunosenescence, and decreased CMI is associated with reactivation of VZV. This article provides an overview of our emerging understanding of the epidemiology and pathogenesis of varicella and HZ, in addition to exploring the current theories on latency and reactivation. Understanding the risk factors for developing HZ and the complications associated with infection, particularly in older people, is important for prompt diagnosis and management of HZ in primary care, and they are therefore also reviewed. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20510263      PMCID: PMC5391040          DOI: 10.1016/S1386-6532(10)70002-0

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  47 in total

1.  Are stressful life events risk factors for herpes zoster?

Authors:  K Schmader; S Studenski; J MacMillan; S Grufferman; H J Cohen
Journal:  J Am Geriatr Soc       Date:  1990-11       Impact factor: 5.562

2.  A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades.

Authors:  Geoffrey A Peters; Shaun D Tyler; Charles Grose; Alberto Severini; Michael J Gray; Chris Upton; Graham A Tipples
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Reactivation of 2 genetically distinct varicella-zoster viruses in the same individual.

Authors:  Y Taha; F T Scott; S P Parker; D Syndercombe Court; M L Quinlivan; J Breuer
Journal:  Clin Infect Dis       Date:  2006-10-11       Impact factor: 9.079

Review 4.  Herpes zoster: epidemiology, natural history, and common complications.

Authors:  Jeffrey M Weinberg
Journal:  J Am Acad Dermatol       Date:  2007-12       Impact factor: 11.527

5.  Varicella-zoster-virus genotypes in East London: a prospective study in patients with herpes zoster.

Authors:  N Sengupta; Y Taha; F T Scott; M E Leedham-Green; M Quinlivan; J Breuer
Journal:  J Infect Dis       Date:  2007-08-29       Impact factor: 5.226

6.  Diabetes as a risk factor for herpes zoster infection: results of a population-based study in Israel.

Authors:  A D Heymann; G Chodick; T Karpati; L Kamer; E Kremer; M S Green; E Kokia; V Shalev
Journal:  Infection       Date:  2008-05-03       Impact factor: 3.553

Review 7.  A review of the varicella vaccine in immunocompromised individuals.

Authors:  Ana Marli Christovam Sartori
Journal:  Int J Infect Dis       Date:  2004-09       Impact factor: 3.623

Review 8.  What does epidemiology tell us about risk factors for herpes zoster?

Authors:  Sara L Thomas; Andrew J Hall
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

9.  Vaccination against Herpes Zoster and Postherpetic Neuralgia.

Authors:  Michael N Oxman; Myron J Levin
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

10.  A model of lytic, latent, and reactivating varicella-zoster virus infections in isolated enteric neurons.

Authors:  Anne A Gershon; Jason Chen; Michael D Gershon
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

View more
  89 in total

1.  Risk of herpes zoster in children with asthma.

Authors:  Chung-Il Wi; Bong-Seong Kim; Sonia Mehra; Barbara P Yawn; Miguel A Park; Young J Juhn
Journal:  Allergy Asthma Proc       Date:  2015 Sep-Oct       Impact factor: 2.587

2.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

Review 3.  A critical appraisal of 'Shingrix', a novel herpes zoster subunit vaccine (HZ/Su or GSK1437173A) for varicella zoster virus.

Authors:  Tehmina Bharucha; Damien Ming; Judith Breuer
Journal:  Hum Vaccin Immunother       Date:  2017-04-20       Impact factor: 3.452

4.  Immunogenicity and safety of a live attenuated shingles (herpes zoster) vaccine (Zostavax®) in individuals aged ≥ 70 years: a randomized study of a single dose vs. two different two-dose schedules.

Authors:  Timo Vesikari; Roland Hardt; Hans C Rümke; Giancarlo Icardi; Jordi Montero; Stéphane Thomas; Christine Sadorge; Anne Fiquet
Journal:  Hum Vaccin Immunother       Date:  2013-01-14       Impact factor: 3.452

Review 5.  Prevention of Herpes Zoster and its complications: From clinical evidence to real life experience.

Authors:  Giovanni Gabutti; Paolo Bonanni; Michele Conversano; Guido Fanelli; Elisabetta Franco; Donato Greco; Giancarlo Icardi; Marzia Lazzari; Alessandro Rossi; Silvestro Scotti; Antonio Volpi
Journal:  Hum Vaccin Immunother       Date:  2016-12-07       Impact factor: 3.452

Review 6.  Reducing the burden of Herpes Zoster in Italy.

Authors:  Giovanni Gabutti; Elisabetta Franco; Paolo Bonanni; Michele Conversano; Antonio Ferro; Marzia Lazzari; Stefania Maggi; Alessandro Rossi; Silvestro Scotti; Francesco Vitale; Antonio Volpi; Donato Greco
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

7.  The burden of disease of Herpes Zoster in Tuscany.

Authors:  Miriam Levi; Irene Bellini; Leonardo Capecchi; Luca Pieri; Angela Bechini; Sara Boccalini; Silvia Callaioli; Roberto Gasparini; Donatella Panatto; Emilia Tiscione; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

8.  Increased risk of herpes zoster in children with asthma: a population-based case-control study.

Authors:  Bong-Seong Kim; Sonia Mehra; Barbara Yawn; Charles Grose; Robert Tarrell; Brian Lahr; Young J Juhn
Journal:  J Pediatr       Date:  2013-04-13       Impact factor: 4.406

9.  The risk factors for herpes zoster in bortezomib treatment in patients with multiple myeloma.

Authors:  Yang-Seon Yi; Joo-Seop Chung; Moo-Kon Song; Ho-Jin Shin; Young-Mi Seol; Young-Jin Choi; Goon-Jae Cho; Gyeong-Won Lee; Joon-Ho Moon; In-Hye Hwang; Kang-Hee Ahn; Hee-Sun Lee; Kyung-Hwa Shin; Jong-Min Hwang
Journal:  Korean J Hematol       Date:  2010-09-30

10.  Mandibular osteonecrosis following herpes zoster infection in the mandibular branch of the trigeminal nerve: a case report and literature review.

Authors:  Jae-Min Song; Jeong-Seok Seo; Jae-Yeol Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2015-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.